Activity of lenalidomide in mantle cell lymphoma can be explained by NK cell-mediated cytotoxicity. (2017)

First Author: Hagner PR
Attributed to:  Institute of Cancer Research Confidence in Concept (ICR CiC) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/bjh.14866

PubMed Identifier: 28771673

Publication URI: http://europepmc.org/abstract/MED/28771673

Type: Journal Article/Review

Volume: 179

Parent Publication: British journal of haematology

Issue: 3

ISSN: 0007-1048